Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities
Net loss	$ (21,825,298)	$ (2,389,018)
Stock-based compensation:
401(k) stock	32,614	27,821
Options	269,965	530,472
Restricted stock units	579,630
Common stock	525,000	105,900
Non-cash lease expense	217,767	194,774
Gain (loss) on foreign currency translation	(478,500)	33,128
Unrealized investment losses		457
Depreciation and amortization	251,941	145,653
Amortization of debt discount	1,172,461	199,161
Provision for uncollectible assets	100,805	183,199
Provision for obsolete inventory	115,563
Gain on forgiveness of PPP Loan		(242,486)
Loss on extinguishment of debt	2,105,119
Inducement expense	3,163,318
Impairment of investment	7,000,000
Decrease (increase) in assets:
Accounts receivable	(608,286)	(4,349,592)
Employee advances	4,053	(11,097)
Inventory	(530,487)	161,637
Deposits		(20,276)
Prepaid expenses and other current assets	(76,691)	(553,345)
Increase (decrease) in liabilities:
Accounts payable and accrued expenses	1,862,137	(479,242)
Operating lease liabilities	(175,316)	(155,484)
Deferred revenue	654,265	(220,325)
Other liabilities	(60,247)	28,683
Total Adjustments	16,125,111	(4,420,962)
Net Cash Used in Operating Activities	(5,700,187)	(6,809,980)
Cash Flows from Investing Activities
Cash paid to acquire GDS, net of cash acquired	(7,560)
Purchase of property and equipment	(1,928,010)	(1,945,266)
Purchase of intangible asset	(34,999)
Purchase of investment - related parties		(7,000,000)
Net Cash Used in Investing Activities	(1,970,569)	(8,945,266)
Cash Flows from Financing Activities
Repayments of loans payable	(116,775)	(185,086)
Proceeds from common stock issued for cash	555,811	5,135,210
Offering costs in connection with common stock issued for cash	(44,465)	(457,810)
Proceeds from the issuance of debt in private placement	1,727,500
Repayments of debt obligations	(7,000)	(100,000)
Proceeds from convertible debt obligations	1,431,500	6,000,000
Proceeds from issuance of shares under the New ELOC	10,086
Offering costs in connection with convertible debt obligations		(470,813)
Proceeds from underwritten public offering		7,287,004
Cash offering costs in connection with the underwritten public offering		(319,684)
Proceeds from sale of common stock and warrants		409,050
Proceeds from the exercise of warrants		1,647,000
Net Cash Provided by Financing Activities	3,556,657	18,944,871
Effect of Exchange Rate Changes on Cash	764,877	325,246
Net (Decrease) Increase in Cash	(3,349,222)	3,514,871
Cash - Beginning of Year	3,649,407	134,536
Cash - End of Year	300,185	3,649,407
Supplemental Disclosures of Cash Flow Information:
Interest paid	215,755	489,291
Income taxes paid		72,531
Non-Cash Investing and Financing Activity
Equity issued to satisfy accrued stock-based compensation expense	27,821
Equity issued as consideration for intangible assets	39,600
Equity issued for purchase of non-controlling interest	231,789
Equity issued for acquisition of GDS	2,194,653
Warrants issued and debt principal exchanged upon modification of convertible debt	834,323
Common stock and warrants issued upon exchange of debt and accrued interest	7,905,560	1,422,068
Common stock and restricted stock units in GGH issued upon exchange of GGI options	1,576,648
Common stock issued to satisfy accrued stock-based compensation		39,537
Series B Preferred stock converted to common stock		9,010,824
Reclassification of deferred offering cost to additional paid in capital		67,016
Common stock and warrants issued to underwriter in public offering		297,963
Common stock issued to placement agent as commitment fees		500,000
Right-of-use assets obtained in exchange for lease obligations		1,861,983
Investor deposits applied to sale of common stock and warrants		29,950
Real estate development costs transferred from property and equipment to lots inventory		$ 882,894